The biopreservation firm reports second-quarter GAAP EPS of $0.02, exceeding analyst expectations by a penny.
BioLife Solutions posted second-quarter GAAP earnings per share of $0.02, beating estimates by $0.01. Revenue reached $27.5M, surpassing projections by $1.84M.
Analysts had anticipated $0.01 EPS and $25.66M in revenue for the quarter. The company’s performance reflects stronger-than-expected demand in its core biopreservation and cold chain logistics segments.
Shares showed limited movement in after-hours trading as investors digested the results.